<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bone marrow (BM) <z:mpath ids='MPATH_133'>hypoplasia</z:mpath> is a major cause of <z:hpo ids='HP_0011420'>death</z:hpo> in <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, little is known about the molecular events leading to the <z:mpath ids='MPATH_133'>hypoplasia</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Considering the close pathologic association between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA), it is suggested that a similar mechanism operates in the development of their BM failure </plain></SENT>
<SENT sid="3" pm="."><plain>Recent reports have indicated <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-mediated BM suppression in AA </plain></SENT>
<SENT sid="4" pm="."><plain>It is thus conceivable that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> also operates to cause BM <z:mpath ids='MPATH_133'>hypoplasia</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>If this is the case, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clones need to survive <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and show considerable expansion leading to clinical manifestations </plain></SENT>
<SENT sid="6" pm="."><plain>We report here that granulocytes obtained from 11 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> were apparently less susceptible than those from 20 healthy individuals to both spontaneous <z:mpath ids='MPATH_3'>apoptosis</z:mpath> without any ligands and that induced by anti-FAS (CD95) antibody in vitro </plain></SENT>
<SENT sid="7" pm="."><plain>The patients' BM CD34+ cells were also resistant to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by treatment with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha, interferon-gamma, and subsequently with anti-FAS antibody </plain></SENT>
<SENT sid="8" pm="."><plain>In lymphocytes, the pathologic resistance was not discriminated from inherent resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Granulocytes from 13 patients with AA and 12 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) exhibited similar resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>CD34+ cells from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-BM also showed similar tendency </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, the comparative resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> supports the pathogenic implication of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in marrow injury of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> and related stem cell disorders </plain></SENT>
</text></document>